LEXEO THERAPEUTICS INC (LXEO) Stock Balance Sheet
NASDAQ:LXEO - US52886X1072 - Common Stock
4.85 USD
-0.04 (-0.82%)
4.85 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.48M | 35.01M | 121.47M | 77.30M | 135.90M | |||
| Marketable Securities | 97.41M | 86.50M | N/A | N/A | N/A | |||
| Other Current Assets | 7.17M | 4.60M | 2.83M | 2.70M | 800.00K | |||
| Total Current Assets | 140.06M | 126.12M | 124.29M | 80.00M | 136.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.76M | 10.56M | 12.26M | 13.80M | 200.00K | |||
| Investments And Advances | 23.00M | 7.01M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.25M | 3.25M | 3.25M | 3.30M | 0.00 | |||
| Total Non-Current Assets | 36.01M | 20.82M | 15.51M | 17.10M | 200.00K | |||
| TOTAL ASSETS | 176.07M | 146.94M | 139.81M | 97.10M | 136.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 520.00K | 570.00K | 518.00K | 500.00K | N/A | |||
| Accrued Expenses | 10.86M | 14.92M | 12.60M | 10.40M | 3.80M | |||
| Accounts Payable | 20.02M | 6.42M | 3.79M | 2.70M | 3.10M | |||
| Other Current Liabilities | 186.00K | 939.00K | 326.00K | 700.00K | 600.00K | |||
| Total Current Liabilities | 31.59M | 22.85M | 17.24M | 14.30M | 7.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 577.00K | 817.00K | 1.25M | 1.60M | 0.00 | |||
| Other Non-Current Liabilities | 5.68M | 6.44M | 7.79M | 9.00M | 0.00 | |||
| Total Non-Current Liabilities | 6.26M | 7.25M | 9.03M | 10.70M | 0.00 | |||
| TOTAL LIABILITIES | 37.85M | 30.10M | 26.27M | 25.00M | 7.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -338.93M | -280.17M | -181.84M | -115.40M | -56.20M | |||
| Additional Paid In Capital | 477.18M | 397.13M | 295.37M | 2.50M | 600.00K | |||
| Common Shares | 5.00K | 3.00K | 3.00K | 185.00M | 185.00M | |||
| Treasury Stock | -17.00K | -17.00K | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -13.00K | -103.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 54.00M | 33.08M | 26.67M | 24.70M | 24.70M | |||
| Tangible Book Value per Share | 2.56 | 3.53 | 4.26 | -4.57 | -2.25 | |||
| Total Shareholders' Equity | 138.22M | 116.84M | 113.53M | 72.10M | 129.40M | |||
| TOTAL LIABILITIES AND EQUITY | 176.07M | 146.94M | 139.81M | 97.10M | 136.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.01 | 0.01 | 0.02 | N/A | |||
| Current Ratio | 4.43 | 5.52 | 7.21 | 5.59 | 18.47 | |||
| Return On Assets (ROA) | -64.85% | -66.69% | -47.49% | -61.05% | -36.98% | |||
| Return On Equity (ROE) | -82.60% | -83.87% | -58.48% | -82.22% | -39.12% | |||
All data in USD , ROIC based on taxRate of 0.21